what states have banned semaglutide State Medicaid Programs Increasingly Opting To Cover Weight-Loss Drugs The FDA-approved GLP-1 pill for

[1] [4] Note that Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved only for type 2 diabetes management, though they contain the same active ingredients

Secondary outcomes include change in waist circumference, change in BMI, change in percent body fat, change in visceral and subcutaneous adipose tissue, change in trunk fat mass, percentage of weight loss due to fat mass or lean mass, quality of life, and more

Clinical experts emphasize that patients must drink fluids regularly to prevent dehydration, which can lead to serious complications, including acute kidney injury

Some patients experience mild digestive discomfort during the adjustment period

Unique Weight Loss and Family Practice: Phentermine vs